US2008044431A1PendingUtilityA1

Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

37
Assignee: SHANAHAN-PRENDERGAST ELIZABETHPriority: Sep 11, 1996Filed: Apr 13, 2007Published: Feb 21, 2008
Est. expirySep 11, 2016(expired)· nominal 20-yr term from priority
Inventors:Elizabeth Shanahan-Prendergast
A61P 9/10A61P 35/00A61P 33/06A61P 37/08A61P 25/18A61P 29/00A61P 11/06A61P 19/02A61P 13/12A61P 17/06A61K 39/395C12Y 301/04011C12Y 301/01004A61K 39/38A61K 35/583C07K 16/40A61K 38/465Y02A50/30
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of treating a mammal prophylactically to prevent neoplastic development comprises administering to the mammal a therapeutic vaccine comprising venom and at least one adjuvant. The method optionally further comprises administering to the mammal at least one other therapeutically effective agent, e.g., an anti-inflammatory agent.

Claims

exact text as granted — not AI-modified
1 - 4 . (canceled)  
   
   
       5 . A method of treating a mammal prophylactically to prevent neoplastic development, comprising administering to said mammal a therapeutic vaccine comprising venom and at least one adjuvant.  
   
   
       6 - 42 . (canceled)  
   
   
       43 . A method according to  claim 5 , further comprising administering to said mammal at least one other therapeutically effective agent.  
   
   
       44 . A method according to  claim 43 , wherein the therapeutic agent is administered as an anti-inflammatory agent.

Join the waitlist — get patent alerts

Track US2008044431A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.